Complement C3d enables protective immunity capable of distinguishing spontaneously transformed from non-transformed cells.

The article highlights the patent application number for research on how Complement C3d enables protective immunity by distinguishing between spontaneously transformed and non-transformed cells, filed by the authors on August 19, 2024. It also discusses the role of C3d in enhancing T cell responses against malignant plasma cells, its effects on immune surveillance through various mechanisms, and the potential therapeutic applications of this discovery.